Catheter Ablation Versus Medical Therapy in Atrial Fibrillation With Heart Failure With Reduced or Mildly Reduced Ejection Fraction: A GRADE ‐Assessed Systematic Review and Meta‐Analysis
Authors:
- Aleena Amir MalikAMAleena Amir Malik
- Nasir SaeedNSNasir Saeed
- Goodluck OparaugoGOGoodluck Oparaugo
- Muhammad Waqar ShahidMSMuhammad Waqar Shahid
- Waqas KareemWKWaqas Kareem
- Fatima YousafFYFatima Yousaf
- Zain Ul AbedeenZAZain Ul Abedeen
- Fatima SajjadFSFatima Sajjad
- Kashif YousafKYKashif Yousaf
- Rubab ZahraRZRubab Zahra
Open Access
- 21 September 2026
- journal article
- review article
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70464
Abstract
Background: Catheter ablation is an established rhythm‐control strategy for atrial fibrillation (AF), but its effectiveness in patients with heart failure with reduced or mildly reduced ejection fraction (HFrEF/HFmrEF) remains incompletely defined. We performed a GRADE‐assessed systematic review and meta‐analysis comparing catheter ablation with conventional medical therapy in this population. Methods: PubMed, Embase, and the Cochrane Library were searched from inception to February 2026. Randomized controlled trials and observational cohort studies enrolling adults with AF and left ventricular ejection fraction (LVEF) ≤ 50% were included. Primary outcomes were all‐cause mortality, cardiovascular mortality, and change in LVEF. Secondary outcomes were change in B‐type natriuretic peptide (BNP) and cardiovascular hospitalization. Random‐effects models were used, and certainty of evidence was assessed using GRADE. Results: Thirteen studies involving 131 492 participants were included. Catheter ablation significantly reduced all‐cause mortality (RR 0.61, 95% CI 0.51–0.71) and cardiovascular mortality (RR 0.46, 95% CI 0.31–0.66), improved LVEF (MD 6.47%, 95% CI 4.47–8.47), and reduced BNP levels (MD −136.85 pg/mL, 95% CI −190.46 to −83.23). No significant reduction was observed in cardiovascular hospitalization (RR 0.78, 95% CI 0.53–1.13). Mortality benefits were consistent across subgroup analyses by study design and baseline LVEF. Conclusions: Catheter ablation was associated with lower mortality and improved cardiac function compared with medical therapy in patients with AF and HFrEF/HFmrEF. Further studies specifically evaluating HFmrEF populations are warranted.Keywords
This publication has 34 references indexed in Scilit:
- Updated Meta‐Analysis of Catheter Ablation Versus Medical Therapy in Atrial Fibrillation With Heart Failure With Preserved Ejection FractionJournal of Arrhythmia, 2025
- Epidemiology of Atrial Fibrillation in Heart FailureCardiac Electrophysiology Clinics, 2024
- Catheter Ablation of Atrial Fibrillation Improves Outcomes in Heart Failure: An Updated Meta-AnalysisESC Heart Failure, 2024
- Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection FractionJAMA Cardiology, 2024
- Efficacy of Catheter Ablation for Atrial Fibrillation in Heart Failure: A Meta-Analysis of Randomized Controlled TrialsESC Heart Failure, 2024
- Long-Term Outcomes Following Catheter Ablation Versus Medical Therapy in Patients with Persistent Atrial Fibrillation and Heart Failure with Reduced Ejection FractionEuropean Journal of Heart Failure, 2022
- Clinical Outcomes and Structural Remodelling After Ablation of Atrial Fibrillation in Heart Failure with Mildly Reduced or Mid-Range Ejection FractionESC Heart Failure, 2022
- Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunctionClinical Cardiology, 2019
- Catheter ablation for treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: A systematic review and meta‐analysisJournal of Arrhythmia, 2019
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986